Asarfi Hospital's Financial Growth and Strong Metrics Prompt Evaluation Adjustment
Asarfi Hospital, a microcap in the healthcare sector, has recently experienced an evaluation adjustment reflecting its improved market position. The company reported strong financial metrics, including a notable return on capital employed and a low debt-to-EBITDA ratio, alongside significant sales growth and impressive annual returns.
Asarfi Hospital, a microcap player in the hospital and healthcare services industry, has recently undergone an evaluation adjustment that reflects its evolving market position. The company has demonstrated notable financial metrics, including a high return on capital employed (ROCE) of 17.91%, indicating strong management efficiency. Additionally, Asarfi Hospital's ability to service its debt is underscored by a low debt-to-EBITDA ratio of 1.14 times.In the latest quarter, the company reported net sales of Rs 35.66 crore, showcasing a growth rate of 25.4% compared to the previous four-quarter average. The profit after tax (PAT) for the last six months stood at Rs 7.03 crore, further highlighting its robust financial health. Over the past year, Asarfi Hospital has generated an impressive return of 165.78%, significantly outpacing the broader market's performance.
The stock's technical indicators have also shown positive trends, with moving averages reflecting bullish signals. Asarfi Hospital's valuation remains attractive, supported by a PEG ratio of 0.2. This combination of strong financial performance and favorable technical trends has contributed to the recent revision in its evaluation.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
